(S)-5-tert-butoxy-4-(3-((S)-1,5-di-tert-butoxy-1,5-dioxopentan-2-yl)ureido)-5-oxopentanoic acid manufacturers
- DUPA(OtBu)-OH
-
- $29.00 / 1mg
-
2024-11-08
- CAS:1026987-94-9
- Min. Order:
- Purity: 97.29%
- Supply Ability: 10g
- DUPA(OtBu)-OH
-
- $29.00 / 1mg
-
2024-11-08
- CAS:1026987-94-9
- Min. Order:
- Purity: 97.29%
- Supply Ability: 10g
|
| (S)-5-tert-butoxy-4-(3-((S)-1,5-di-tert-butoxy-1,5-dioxopentan-2-yl)ureido)-5-oxopentanoic acid Basic information | Uses |
Product Name: | (S)-5-tert-butoxy-4-(3-((S)-1,5-di-tert-butoxy-1,5-dioxopentan-2-yl)ureido)-5-oxopentanoic acid | Synonyms: | (S)-5-tert-butoxy-4-(3-((S)-1,5-di-tert-butoxy-1,5-dioxopentan-2-yl)ureido)-5-oxopentanoic acid;2-[3-(1,3-bis-tert-butoxycarbonylpropyl)ureido]pentanedioic acid 1-tert-butyl ester;(R)-5-(tert-butoxy)-4-(3-((S)-1,5-di-tert-butoxy-1,5-dioxopentan-2-yl)ureido)-5-oxopentanoic acid;Inhibitor,DUPA(OtBu)-OH,DUPA(OtBu)OH,DUPA(OtBu) OH,inhibit;L-Glutamic acid, N-[[[(1S)-3-carboxy-1-[(1,1-dimethylethoxy)carbonyl]propyl]amino]carbonyl]-, 1,5-bis(1,1-dimethylethyl) ester;DUPA(OtBu)3-OH | CAS: | 1026987-94-9 | MF: | C23H40N2O9 | MW: | 488.57 | EINECS: | | Product Categories: | | Mol File: | 1026987-94-9.mol | |
| (S)-5-tert-butoxy-4-(3-((S)-1,5-di-tert-butoxy-1,5-dioxopentan-2-yl)ureido)-5-oxopentanoic acid Chemical Properties |
Melting point | 120-123°C | Boiling point | 627.6±55.0 °C(Predicted) | density | 1.139±0.06 g/cm3(Predicted) | storage temp. | Refrigerator | solubility | Chloroform (Sparingly), Methanol (Slightly) | form | Solid | pka | 4.46±0.10(Predicted) | color | White to Off-White | InChIKey | KBDDHSXZOLZZGF-GJZGRUSLSA-N | SMILES | C(OC(C)(C)C)(=O)[C@H](CCC(OC(C)(C)C)=O)NC(N[C@H](C(OC(C)(C)C)=O)CCC(O)=O)=O |
| (S)-5-tert-butoxy-4-(3-((S)-1,5-di-tert-butoxy-1,5-dioxopentan-2-yl)ureido)-5-oxopentanoic acid Usage And Synthesis |
Uses | (S)-5-tert-Butoxy-4-(3-((s)-1,5-di-tert-butoxy-1,5-dioxopentan-2-yl)ureido)-5-oxopentanoic Acid is used as a reactant in the synthesis of a DUPA-paclitaxel conjugate for antigen targeted therapy of prostate cancer. | Uses | (S)-5-tert-Butoxy-4-(3-((s)-1,5-di-tert-butoxy-1,5-dioxopentan-2-yl)ureido)-5-oxopentanoic Acid is used as a reactant in the synthesis of a DUPA-paclitaxel conjugate for antigen targeted therapy of prostate cancer. |
| (S)-5-tert-butoxy-4-(3-((S)-1,5-di-tert-butoxy-1,5-dioxopentan-2-yl)ureido)-5-oxopentanoic acid Preparation Products And Raw materials |
|